AstraZeneca’s Phase III Lung Cancer Data Fails to Hit the Mark With Investors

July 5, 2023

AstraZeneca Scores Win as Imfinzi, Imjudo Delay Liver Cancer Progression

April 3, 2026

Experimental Pill by Novo Nordisk Shown to Have Side Effects in Trial

September 26, 2024

Must Read

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

May 22, 2026

The AI Talent War in Life Sciences Is Just Beginning

May 22, 2026

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

May 22, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

BioMarin Reports Phase 3 Growth Improvements for Voxzogo in Hypochondroplasia

Immunovant Forced to Pay Out to Scrap FcRn Inhibitor Following Phase 3 Failure

Parabilis Plans Phase 3 Trial of Zolucatetide for Desmoid Tumors

Incyte Expands Genesis AI Drug Discovery Partnership in Deal Worth Over $1 Billion

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

The AI Talent War in Life Sciences Is Just Beginning

What Makes Life Sciences Data “AI-Ready”?

Synthetic Data in Healthcare: The Next Frontier or a Compliance Risk?

Clinical

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

Editor Picks

AstraZeneca’s Phase III Lung Cancer Data Fails to Hit the Mark With Investors

AstraZeneca Scores Win as Imfinzi, Imjudo Delay Liver Cancer Progression

Experimental Pill by Novo Nordisk Shown to Have Side Effects in Trial

Must Read

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

The AI Talent War in Life Sciences Is Just Beginning

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

Hot Topics

About Us

Follow Us